Literature DB >> 8482294

The cost associated with intraperitoneal versus subcutaneous administration of erythropoietin.

W Lane, M Robson, A K Leung, J E Zaretski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8482294     DOI： 10.1007/bf01956759

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  3 in total

1.  Anemia of chronic renal failure: treatment with erythropoietin.

Authors:  M Navarro; A Alonso; J M Avilla; L Espinosa
Journal:  Child Nephrol Urol       Date:  1991

2.  Intraperitoneal administration of recombinant human erythropoietin in children on continuous ambulatory peritoneal dialysis.

Authors:  R E Reddingius; C H Schröder; L A Monnens
Journal:  Eur J Pediatr       Date:  1992-07       Impact factor: 3.183

3.  Use of subcutaneous recombinant human erythropoietin in children undergoing continuous cycling peritoneal dialysis.

Authors:  L Sinai-Trieman; I B Salusky; R N Fine
Journal:  J Pediatr       Date:  1989-04       Impact factor: 4.406
  3 in total
  1 in total

1.  Pharmacokinetics of recombinant human erythropoietin in children treated with continuous ambulatory peritoneal dialysis.

Authors:  R E Reddingius; C H Schröder; A M Koster; L A Monnens
Journal:  Eur J Pediatr       Date:  1994-11       Impact factor: 3.183
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.